Scientists identify common molecular program across multiple brain tumor types
Research uncovering the origin of pineoblastoma, a rare pediatric brain tumor, has also revealed a dependency across multiple…
Trial aims to improve family communication about inherited colorectal cancer risk
In time for Colorectal Cancer Awareness Month in March, the Alliance for Clinical Trials in Oncology has launched…
New fragmentome technology can detect early liver fibrosis and cirrhosis
Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test using genome-wide cell-free…
Common cardio drugs proven safe in myeloma patients
Commonly prescribed cardiovascular medications—such as statins, diuretics, and blood pressure drugs—appear to have little or no negative impact…
Exercise during chemotherapy boosts breast cancer patients’ quality of life
For many women with breast cancer, the very treatment that saves their lives can also bring fatigue, loss…
Innovative laser procedure offers new hope for recurrent brain tumors
High-grade astrocytoma, which includes glioblastoma, is a fast-growing, aggressive brain cancer that often returns after the tumor is removed, making it…
Stilbenoid gaylussacin modulates particulate matter-induced chromatin remodeling in macrophages to suppress chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD), a leading cause of mortality worldwide, is characterized by chronic bronchitis and emphysema.1…
Alzheimer’s plaques decline after CAR-T immune cell treatment in preclinical study
A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the possibility that engineered immune…
Crick spin‑out ALTx will target cancer cell immortality
 Founded in late 2024, ALTx Therapeutics has come out of stealth mode with plans to develop therapies…
University of Missouri launches first on-campus radiopharmaceutical clinical trial
In a major leap for cancer care at the University of Missouri, the School of Medicine and MU…
Reprogrammed neutrophils promote tumor growth
Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE)…
Study shows DHPS enzyme controls macrophage maturation across multiple organs
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns…